Methylsulfonylmethane and boswellic acids versus glucosamine sulfate in the treatment of knee arthritis: Randomized trial - PubMed (original) (raw)

Randomized Controlled Trial

Methylsulfonylmethane and boswellic acids versus glucosamine sulfate in the treatment of knee arthritis: Randomized trial

Angela Notarnicola et al. Int J Immunopathol Pharmacol. 2016 Mar.

Abstract

Until now glucosamine sulfate (GS) has been the most widely used supplement and has been shown to be efficacious in the treatment of osteoarthritis (OA). Methylsulfonylmethane (MSM) and boswellic acids (BA) are new effective supplements for the management of inflammation and joint degeneration, according to previous experimental studies. The aim of our study is to test the effectiveness of association of MSM and BA in comparison with GS in knee arthritis.In this prospective randomized clinical trial, MEBAGA (Methylsulfonylmethane and Boswellic Acids versus Glucosamine sulfate in the treatment of knee Arthritis), 120 participants affected by arthritis of the knee were randomly assigned to an experimental group (MB group) or a control group (GS group) treated for 60 days with 5 g of MSM and 7.2 mg of BA or with 1500 mg of GS daily, respectively. At the 2-month (T1) and 6-months (T2) follow-up , the efficacy of these two nutraceuticals was assessed using the visual analog pain scale (VAS) and the Lequesne Index (LI) for joint function, along with the use of anti-inflammatory drugs (non-steroidal anti-inflammatory drugs and anti-cyclooxygenase-2).The repeated measures ANOVA analysis shows that for VAS, LI, and the use of anti-inflammatory drugs scores there are improvements due to the time in the two groups (respectively, F=26.0; P<0.0001; F=4.15; P=0.02; F=3.38; P=0.04), with a tendency to better values for the MB group at T2.On the basis of these preliminary data, we could support the efficacy of the MSM in association with BA in the treatment of OA. These results are consistent with the anti-inflammatory and chondroprotective effects previously occurred in experimental studies. This new combination of integration (MSM and BS) has presented good results and satisfactory in comparison with GS, until now the cornerstone of the treatment of arthritis in according to guidelines.

Keywords: boswellic acid; glucosamine; knee; methylsulfonylmethane; osteoarthritis.

© The Author(s) 2015.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interest: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Similar articles

Cited by

References

    1. Berenbaum F. (2013) Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis and Cartilage 21(1): 16–21. - PubMed
    1. McAlindon TE, Bannuru RR, Sullivan MC, et al. (2014) OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis and Cartilage 22(3): 363–388. - PubMed
    1. Simon LS. (2013) Nonsteroidal anti-inflammatory drugs and their risk: A story still in development. Arthritis Research & Therapy 15 (Suppl. 3): S1. - PMC - PubMed
    1. Vista ES, Lau CS. (2011) What about supplements for osteoarthritis? A critical and evidenced-based review. International Journal of Rheumatic Diseases 14(2): 152–158. - PubMed
    1. Rozendaal RM, Koes BW, Weinans H, et al. (2005) The effect of glucosamine sulphate on osteoarthritis: Design of a long-term randomised clinical trial [ISRCTN54513166]. BMC Musculoskeletal Disorders 6: 20. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources